Related references
Note: Only part of the references are listed.Lessons From HIV Therapy Applied to Viral Hepatitis Therapy: Summary of a Workshop
Alexander Monto et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Detection of E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir Resistance
Margaret Okomo-Adhiambo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Recovery of a Multidrug-Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y/I223R Mutation from a Child after Prolonged Treatment with Oseltamivir
Ha T. Nguyen et al.
CLINICAL INFECTIOUS DISEASES (2010)
Antiretroviral Treatment of Adult HIV Infection 2010 Recommendations of the International AIDS Society-USA Panel
Melanie A. Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Rapid quantification of single-nucleotide mutations in mixed influenza A viral populations using allele-specific mixture analysis
Cindy M. Liu et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
Dynamics of Influenza Virus Infection and Pathology
Roberto A. Saenz et al.
JOURNAL OF VIROLOGY (2010)
Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus.
Erhard van der Vries et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro
Jack T. Nguyen et al.
PLOS ONE (2010)
Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro
Jack T. Nguyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Why Amantadine Loses Its Function in Influenza M2 Mutants: MD Simulations
Chittima Laohpongspaisan et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation
Aeron C. Hurt et al.
JOURNAL OF VIROLOGY (2009)
Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007-08
Siri H. Hauge et al.
EMERGING INFECTIOUS DISEASES (2009)
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008
Tiffany G. Sheu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Kinetics of influenza A virus infection in humans
Prasith Baccam et al.
JOURNAL OF VIROLOGY (2006)
The survival benefits of AIDS treatment in the United States
Rochelle P. Walensky et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants
Natalia A. Ilyushina et al.
ANTIVIRAL RESEARCH (2006)
Comparison of the mutation rates of human influenza A and B viruses
E Nobusawa et al.
JOURNAL OF VIROLOGY (2006)
Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection
MD de Jong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors
VP Mishin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Confronting the emergence of drug-resistant HIV type 1: Impact of antiretroviral therapy on individual and population resistance
ES Daar et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2005)
Mathematical model of influenza A virus production in large-scale microcarrier culture
L Möhler et al.
BIOTECHNOLOGY AND BIOENGINEERING (2005)
Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations
Y Abed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Lethal mutagens: broad-spectrum antivirals with limited potential for development of resistance?
MS Freistadt et al.
DRUG RESISTANCE UPDATES (2004)
Overexpression of the α-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors
M Matrosovich et al.
JOURNAL OF VIROLOGY (2003)
Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene
Y Abed et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy
R Jordan et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Share Paper
